Nirmala Sitharaman has lived up to her promise of delivering a historical Budget. This has sent the markets into an unstoppable Bull Run. Some savvy traders are effortlessly raking in mammoth gains & breaking records
Subscribe to Blog via Email
Join 486 other subscribers
- JTL Industries has ascended as the fastest-growing co. Target Price ₹294 (37.5% upside)JTL Industries has ascended as the fastest-growing co propelled by robust sectoral dynamics, augmented production capacities & strong offtake. Its strategic decision to prioritize value-added product segments has proven to be effective. TP ₹294 (+37.6%) https://rakesh-jhunjhunwala.in/jtl-...y-for-target-price-of-₹294-37-6-upside-smifs/... JTL Industries has ascended as the fastest-growing co. Target Price ₹294 (37.5% upside)
- Buy TRIL for Target Price of ₹980 (45% upside)TRIL: HV power transformer manufacturers are seeing a Goldilocks phase of T&D cycle - high demand (domestic +exports) coupled with short supply spurring premium pricing & margins. TRIL's order book is ₹35Bn, margin outperformance continues. TP ₹980 (45%) Download research report... Buy TRIL for Target Price of ₹980 (45% upside)
- ValueQuest Moat Fund has invested in 1.17% of MSTC worth ₹59 Cr.ValueQuest Moat Fund has invested in 1.17% of MSTC worth ₹59 Cr. Govt holds 65%. M-Cap is ₹4900 Cr. Co earns by conducting auctions (e-commerce) for other PSUs & Govt Depts. Scrap recovery is a main business. RoCE is 37%, RoE is 27%, Dividend yield is 2.4%. Co is net debt-free
Recent Posts
- Hyundai Motors India is a credible play on tangible growth story in PV space. Subscribe to the IPO: ICICI Direct
- JTL Industries Ltd’s Capex to stimulate growth; value-addition to aid margins. Buy for target price of ₹294 (37.6% upside): SMIFS
- TRIL’s margin outperformance continues. Buy for target price of ₹980 (45% upside): Nuvama
- Skipper Ltd is poised for a powerful performance. Buy for target price of ₹650 (44% upside): Nuvama
- Jubilant Pharmova has a unique business with long-term earnings visibility. BUY for target price of ₹1450 (30% upside): Nuvama
Recent Comments